These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7267673)

  • 21. One-week therapy with omeprazole, clarithromycin and metronidazole or ornidazole, followed by 3 weeks' treatment with omeprazole, eradicates Helicobacter pylori equally and heals duodenal ulcer.
    Tzivras M; Archimandritis A; Balatsos V; Delis V; Souyioultzis S; Skandalis N; Kanellopoulou E; Manika Z; Davaris P
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1185-9. PubMed ID: 9471024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
    Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
    Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Report on the effective dose of a new cephalosporin in peroral administration: cephalexin].
    Russo R; Scianaro D; Pagliarulo V
    Clin Ter; 1972 Jun; 61(5):419-40. PubMed ID: 5051326
    [No Abstract]   [Full Text] [Related]  

  • 24. Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group [corrected].
    Iravani A; Tice AD; McCarty J; Sikes DH; Nolen T; Gallis HA; Whalen EP; Tosiello RL; Heyd A; Kowalsky SF
    Arch Intern Med; 1995 Mar; 155(5):485-94. PubMed ID: 7864704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Report of experiences with the oral cephalosporin-derivative cephaclor in respiratory tract infections].
    Spath P
    Wien Med Wochenschr; 1983 Jan; 133(1):27-30. PubMed ID: 6837048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of skin and skin structure infections.
    Rodriguez-Noriega E; Esparza-Ahumada S; Morfin-Otero R
    J Chemother; 1995 Jun; 7 Suppl 2():155-60. PubMed ID: 8622105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of streptococcal pharyngitis with once-daily compared with twice-daily amoxicillin: a noninferiority trial.
    Clegg HW; Ryan AG; Dallas SD; Kaplan EL; Johnson DR; Norton HJ; Roddey OF; Martin ES; Swetenburg RL; Koonce EW; Felkner MM; Giftos PM
    Pediatr Infect Dis J; 2006 Sep; 25(9):761-7. PubMed ID: 16940830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of twice-daily amoxycillin/clavulanate in lower respiratory tract infections.
    Balgos AA; Rodriguez-Gomez G; Nasnas R; Mahasur AA; Margono BP; Tinoco-Favila JC; Sansores-Martinez RH; Hassan M; Beppo O; Wongsa A; Cukier A; Vargas F
    Int J Clin Pract; 1999; 53(5):325-30. PubMed ID: 10695094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of the drug events reported by 12,917 patients treated with cephalexin.
    Burt RA
    Postgrad Med J; 1983; 59 Suppl 5():47-53. PubMed ID: 6364090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of twice-daily amoxycillin/clavulanate ('Augmentin-Duo' 400/57) in mild to moderate lower respiratory tract infection in children.
    Cook RC; Zachariah J; Cree F; Harrison HE
    Br J Clin Pract; 1996; 50(3):125-8. PubMed ID: 8733329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Azithromycin effect on helicobacter pylori eradication: double blind randomized clinical trial.
    Rogha M; Pourmoghaddas Z; Rezaee M; Shirneshan K; Shahi Z
    Hepatogastroenterology; 2009; 56(91-92):722-4. PubMed ID: 19621690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions between amprenavir and the lopinavir-ritonavir combination in heavily pretreated patients infected with human immunodeficiency virus.
    Taburet AM; Raguin G; Le Tiec C; Droz C; Barrail A; Vincent I; Morand-Joubert L; Chêne G; Clavel F; Girard PM
    Clin Pharmacol Ther; 2004 Apr; 75(4):310-23. PubMed ID: 15060509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis.
    Dignass AU; Bokemeyer B; Adamek H; Mross M; Vinter-Jensen L; Börner N; Silvennoinen J; Tan G; Pool MO; Stijnen T; Dietel P; Klugmann T; Vermeire S; Bhatt A; Veerman H
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):762-9. PubMed ID: 19375519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the efficacy of sequential intravenous-oral administration of pefloxacin in community-acquired lower respiratory tract infections in patients with underlying conditions.
    Yap JC; Wang YT; Chan CC; Ng A; Poh SC
    Singapore Med J; 1995 Oct; 36(5):484-6. PubMed ID: 8882529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of acute lower respiratory tract infections caused by gram-negative organisms.
    Covi M; Velluti G
    J Chemother; 1995 Jun; 7 Suppl 2():137-42. PubMed ID: 8622102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pharmacology of cephalexin.
    Griffith RS
    Postgrad Med J; 1983; 59 Suppl 5():16-27. PubMed ID: 6364086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cephalexin in internal medicine. Antibacterial treatment in 30 patients, 10 of them with malignant hemopathies, including 6 cases of agranulocytosis (granulocytes 1500/mm3)].
    Mizon JP; Gentit F
    Lille Med; 1975 Jan; 20(1):58-60. PubMed ID: 124374
    [No Abstract]   [Full Text] [Related]  

  • 38. Cephalexin therapy for infections in the elderly and other vulnerable patients.
    Cooke DM; Browning AK
    Curr Med Res Opin; 1980; 7(1):62-7. PubMed ID: 7428416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cephalexin therapy for infections complicated by age and concurrent diseases. A study in general practice.
    Cooke DM
    Chemotherapy; 1979; 25(6):356-61. PubMed ID: 520078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Oral cephalexin therapy of osteomyelitis (author's transl)].
    Endler M; Hackel H
    Wien Med Wochenschr; 1979 Feb; 129(4):107-11. PubMed ID: 425547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.